Acquirement and disappearance of HBsAg and anti-HCV in an aged population: A follow-up study in an endemic township

Liver International

Volumn 31, Issue 7, 2011, Pages 971-979

  Tsai, Pei Shan ^a,b   Chang, Chang Jung ^c,d   Chen, Kow Tong ^b   Chang, Kuo Chin ^c,d   Hung, Shu Fen ^c   Wang, Jing Houng ^c,d   Hung, Chao Hung ^c,d   Chen, Chien Hung ^c,d   Tseng, Po Lin ^c,d   Kee, Kwong Ming ^c,d   Yen, Yi Hao ^c,d   Tsai, Chin Chen ^a   Lu, Sheng Nan ^c,d  

^a Health Center of Zihguan Township   (Taiwan)

^b NATIONAL CHENG KUNG UNIVERSITY   (Taiwan)

^c CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

^d CHANG GUNG UNIVERSITY   (Taiwan)

Author keywords

Anti HBc alone; Anti HCV; Community based study; HBsAg; Seroclearance; Seroreversion

Indexed keywords

ALANINE AMINOTRANSFERASE; HEPATITIS B CORE ANTIBODY; HEPATITIS B SURFACE ANTIBODY; HEPATITIS B SURFACE ANTIGEN; HEPATITIS C ANTIBODY; VIRUS DNA; VIRUS RNA;

AGED; ARTICLE; ECHOGRAPHY; FEMALE; FOLLOW UP; HEPATITIS C VIRUS; HEPATITIS DELTA VIRUS; HUMAN; MALE; NONHUMAN; RISK FACTOR; SEROCONVERSION; VIREMIA;

ABDOMEN; AGED; ALANINE TRANSAMINASE; FEMALE; FOLLOW-UP STUDIES; HEPATITIS B; HEPATITIS B SURFACE ANTIGENS; HEPATITIS C; HEPATITIS C ANTIBODIES; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; QUESTIONNAIRES; SEROEPIDEMIOLOGIC STUDIES; TAIWAN;

EID: 79960104484     PISSN: 14783223     EISSN: 14783231     Source Type: Journal    
DOI: 10.1111/j.1478-3231.2010.02363.x     Document Type: Article

References (47)

1. Bréchot C, Thiers V, Kremsdorf D, et al. Persistent hepatitis B virus infection in subjects without hepatitis B surface antigen: clinically significant or purely "occult"? Hepatology 2001; 34: 194-203.
2. Arase Y, Ikeda K, Suzuki F, et al. Long-term outcome after hepatitis B surface antigen seroclearance in patients with chronic hepatitis B. Am J Med 2006; 119: e9-16.
3. Chen YC, Sheen IS, Chu CM, Liaw YF. Prognosis following spontaneous HBsAg seroclearance in chronic hepatitis B patients with or without concurrent infection. Gastroenterology 2002; 123: 1084-9.
4. Huo TI, Wu JC, Lee PC, et al. Sero-clearance of hepatitis B surface antigen in chronic carriers does not necessarily imply a good prognosis. Hepatology 1998; 28: 231-6.
5. Weber B, Melchior W, Gehrke R, et al. Hepatitis B virus markers in anti-HBc only positive individuals. J Med Virol 2001; 64: 312-9.
6. Colomina-Rodríguez J, González-García D, Burgos-Teruel A, Fernández-Lorenz N, Guerrero-Espejo A. Significance of hepatitis B core antibody as the only marker of hepatitis B infection. Enferm Infecc Microbiol Clin 2005; 23: 80-5.
7. Kondili LA, Chionne P, Costantino A, et al. Infection rate and spontaneous seroreversion of anti-hepatitis C virus during the natural course of hepatitis C virus infection in the general population. Gut 2002; 50: 693-6.
8. Seeff LB, Hollinger FB, Alter HJ, et al. Long-term mortality and morbidity of transfusion-associated non-A, non-B, and type C hepatitis: a National Heart, Lung, and Blood Institute Collaborative Study. Hepatology 2001; 33: 455-63.
9. Simon N, Couroucé AM, Lemarrec N, Trépo C, Ducamp S. A twelve-year natural history of hepatitis C virus infection in hemodialyzed patients. Kidney Int 1994; 46: 504-11.
10. Lu SN, Chue PY, Chen HC, et al. Different viral aetiology of hepatocellular carcinoma between two hepatitis B and C endemic townships in Taiwan. J Gastroenterol Hepatol 1997; 12: 547-50.
11. Lu SN, Chue PY, Chen IL, et al. Incidence of hepatitis C infection in a hepatitis C endemic township in southern Taiwan. Kaohsiung J Med Sci 1997; 13: 605-8.
12. Lu SN, Chen TM, Lee CM, et al. Molecular epidemiological and clinical aspects of hepatitis D virus in a unique triple hepatitis viruses (B, C, D) endemic community in Taiwan. J Med Virol 2003; 70: 74-80.
13. Huang JF, Lu SN, Chue PY, et al. Hepatitis C virus infection among teenagers in an endemic township in Taiwan: epidemiological and clinical follow-up studies. Epidemiol Infect 2001; 127: 485-92.
14. Department of Health. Atlas of Cancer Mortality in Taiwan, 1972-2001. Taipei, ROC: Department of Health, 2003.
15. Lu SN, Lee CM, Changchien CS, Chen CJ. Excess mortality from hepatocellular carcinoma in an HCV-endemic township of an HBV-endemic country (Taiwan). Trans R Soc Trop Med Hyg 1999; 93: 600-2.
16. Ognibene A, Drake CJ, Jeng KY, et al. A new modular chemiluminescence immunoassay analyser evaluated. Clin Chem Lab Med 2000; 38: 251-60.
17. Hung CH, Lu SN, Wang JH, et al. Correlation between ultrasonographic and pathologic diagnoses of hepatitis B and C virus-related cirrhosis. J Gastroenterol 2003; 38: 153-7.
18. Chen CH, Yang PM, Huang GT, et al. Estimation of seroprevalence of hepatitis B virus and hepatitis C virus in Taiwan from a large-scale survey of free hepatitis screening participants. J Formos Med Assoc 2007; 106: 148-55.
19. Chu CM, Liaw YF. HBsAg seroclearance in asymptomatic carriers of high endemic areas: appreciably high rates during a long-term follow-up. Hepatology 2007; 45: 1187-92.
20. Liaw YF, Yang SS, Chen TJ, Chu CM. Acute exacerbation in hepatitis B e antigen positive chronic type B hepatitis. A clinicopathological study. J Hepatol 1985; 1: 227-33.
21. Adachi H, Kaneko S, Matsushita E, et al. Clearance of HBsAg in seven patients with chronic hepatitis B. Hepatology 1992; 16: 1334-47.
22. Chen CH, Lee CM, Wang JH, et al. Correlation of quantitative assay of hepatitis B surface antigen and HBV DNA levels in asymptomatic hepatitis B virus carriers. Eur J Gastroenterol Hepatol 2004; 16: 1213-8.
23. Liu J, Yang HI, Lee MH, et al. Incidence and determinants of spontaneous hepatitis B surface antigen seroclearance: a community-based follow-up study. Gastroenterology 2010; 139: 474-82.
24. Tai DI, Tsay PK, Chen WT, Chu CM, Liaw YF. Relative roles of HBsAg seroclearance and mortality in the decline of HBsAg prevalence with increasing age. Am J Gastroenterol 2010; 105: 1102-9.
25. Pondé RA, Cardoso DD, Ferro MO. The underlying mechanisms for the 'anti-HBc alone' serological profile. Arch Virol 2010; 155: 149-58.
26. Lu SN, Chen CH, Chen TM, et al. Hepatitis B virus infection in adolescents in a rural township - 15 years subsequent to mass hepatitis B vaccination in Taiwan. Vaccine 2006; 24: 759-65.
27. Chan CY, Lee SD, Tsai YT, Lo KJ. Hepatitis B vaccination alone is not adequate for the categorizing of adult subjects with isolated anti-HBc. J Gastroenterol Hepatol 1995; 10: 192-7.
28. Berrajah-Fki L, Ben Halima S, Guermazi F, Hammami A, Karray-Hakim H. Significance of "anti HBc alone" serological profile in 284 patients suspicious of being infected with hepatitis B virus. Ann Biol Clin (Paris) 2006; 64: 451-5.
29. Gross A, Joller-Jemelka HI, Wicki AN, Grob PJ. Hepatitis serological finding "anti-HBc alone", circulating viral DNA and interpretation of findings. Schweiz Med Wochenschr 1993; 123: 1193-202.
30. Grob P, Jilg W, Bornhak H, et al. Serological pattern "anti-HBc alone": report on a workshop. J Med Virol 2000; 62: 450-5.
31. Chen TM, Lu SN, Wang JH, Tung HD. The prevalence and its meaning of anti-HBc alone 15 years subsequent to mass hepatitis B vaccination. J Intern Med Taiwan 2002; 13: 247-55.
32. Yen YH, Chen CH, Wang JH, et al. Study of hepatitis B (HB) vaccine non-responsiveness among health care workers from an endemic area (Taiwan). Liver Int 2005; 25: 1162-8.
33. Sun HY, Lee HC, Liu CE, et al. Factors associated with isolated anti-hepatitis B core antibody in HIV-positive patients: impact of compromised immunity. J Viral Hepat 2010; 17: 578-87.
34. Liaw YF, Chen YC, Sheen IS, Chien RN, Yeh CT, Chu CM. Impact of acute hepatitis C virus superinfection in patients with chronic hepatitis B virus infection. Gastroenterology 2004; 126: 1024-9.
35. Niro GA, Gravinese E, Martini E, et al. Clearance of hepatitis B surface antigen in chronic carriers of hepatitis delta antibodies. Liver 2001; 21: 254-9.
36. Huang CF, Huang JF, Dai CY, et al. Changing prevalence of hepatitis C virus infection among teenagers in an endemic area in Taiwan. Trans R Soc Trop Med Hyg 2008; 102: 929-34.
37. Hung CH, Lu SN, Wang JH, et al. Identified cases of acute hepatitis C from computerized laboratory database: a hospital-based epidemiological and clinical study. J Infect 2008; 56: 274-80.
38. Lu SN, Chen HC, Tang CM, et al. Prevalence and manifestations of hepatitis C seropositivity in children in an endemic area. Pediatr Infect Dis J 1998; 17: 142-5.
39. Seeff LB. Natural history of chronic hepatitis C. Hepatology 2002; 36: S35-46.
40. Huang WS, Lu SN, Wang JH, et al. Prediction of viremia for cases of hepatitis C virus (HCV) infection using a third-generation anti-HCV enzyme immunoassay test. Hepatogastroenterology 2005; 52: 893-6.
41. Tung HD, Lu SN, Lee CM, et al. Antiviral treatment responses in patients with chronic hepatitis C virus infection evaluated by a third generation anti-hepatitis C virus assay. J Viral Hepat 2002; 9: 304-8.
42. Liaw YF, Yeh CT, Tsai SL. Impact of acute hepatitis B virus superinfection on chronic hepatitis C virus infection. Am J Gastroenterol 2000; 95: 2978-80.
43. Martín-Carbonero L, Barreiro P, Jiménez-Galán G, et al. Clearance of hepatitis C virus in HIV-infected patients with multiple chronic viral hepatitis. J Viral Hepat 2007; 14: 392-5.
44. Chang KC, Tsai PS, Hsu MC, et al. Chronic hepatitis C increased the mortality rates of patients with hepatocellular carcinoma and diabetes mellitus in a triple hepatitis virus endemic community. J Gastroenterol 2010; 45: 636-45.
45. Yu ML, Chuang WL, Chen SC, et al. Changing prevalence of hepatitis C virus genotypes: molecular epidemiology and clinical implications in the hepatitis C virus hyperendemic areas and a tertiary referral center in Taiwan. J Med Virol 2001; 65: 58-65.
46. Liang SH, Chen TJ, Lee SS, et al. Risk factors of isolated antibody against core antigen of hepatitis B virus: association with HIV infection and age but not hepatitis C virus infection. J Acquir Immune Defic Syndr 2010; 54: 122-8.
47. Chang CJ, Chiang JC, Lu SN, Wang JH. Hepatitis delta virus and GBV-C infection in two neighboring hepatitis B virus and hepatitis C virus-endemic villages in Taiwan. Chang Gung Med J 2010; 33: 137-44.